171 related articles for article (PubMed ID: 7529077)
1. The c-kit molecule and the surface immunophenotype of human acute leukemia.
Kubota A; Okamura S; Shimoda K; Harada M; Niho Y
Leuk Lymphoma; 1994 Aug; 14(5-6):421-8. PubMed ID: 7529077
[TBL] [Abstract][Full Text] [Related]
2. Granulocyte-colony stimulating factor, granulocyte-macrophage colony stimulating factor, PIXY-321, stem cell factor, interleukin-3, and interleukin-7: receptor binding and effects on clonogenic proliferation in acute lymphoblastic leukemia.
Drach D; Estrov Z; Zhao S; Drach J; Cork A; Collins D; Kantarjian H; Andreeff M
Leuk Lymphoma; 1994 Dec; 16(1-2):79-88. PubMed ID: 7535143
[TBL] [Abstract][Full Text] [Related]
3. Granulocyte colony-stimulating factor receptors on human acute leukemia: biphenotypic leukemic cells possess granulocyte colony-stimulating factor receptors.
Shimoda K; Okamura S; Harada N; Ikematsu W; Kondo S; Kawasaki C; Tanaka T; Etou T; Akashi K; Okamura T
Cancer Res; 1992 Jun; 52(11):3052-5. PubMed ID: 1534271
[TBL] [Abstract][Full Text] [Related]
4. Expression of type III receptor tyrosine kinases FLT3 and KIT and responses to their ligands by acute myeloid leukemia blasts.
Stacchini A; Fubini L; Severino A; Sanavio F; Aglietta M; Piacibello W
Leukemia; 1996 Oct; 10(10):1584-91. PubMed ID: 8847893
[TBL] [Abstract][Full Text] [Related]
5. Tumor necrosis factor alpha (TNF alpha) downregulates c-kit proto-oncogene product expression in normal and acute myeloid leukemia CD34+ cells via p55 TNF alpha receptors.
Khoury E; Andre C; Pontvert-Delucq S; Drenou B; Baillou C; Guigon M; Najman A; Lemoine FM
Blood; 1994 Oct; 84(8):2506-14. PubMed ID: 7522632
[TBL] [Abstract][Full Text] [Related]
6. Effects of mast cell growth factor on Ara-C mediated acute myeloid leukemia cell killing.
Tafuri A; De Felice L; Mascolo MG; Valentini T; Petrucci MT; Petti MC
Stem Cells; 1993 Jul; 11 Suppl 2():88-92. PubMed ID: 7691332
[TBL] [Abstract][Full Text] [Related]
7. AML: immunophenotypic heterogeneity and prognostic significance of c-kit expression.
Reuss-Borst MA; Bühring HJ; Schmidt H; Müller CA
Leukemia; 1994 Feb; 8(2):258-63. PubMed ID: 7508533
[TBL] [Abstract][Full Text] [Related]
8. Expansion of cord blood progenitors and use for hemopoietic reconstitution.
Gabutti V; Timeus F; Ramenghi U; Crescenzio N; Marranca D; Miniero R; Cornaglia G; Bagnara GP
Stem Cells; 1993 Jul; 11 Suppl 2():105-12. PubMed ID: 7691315
[TBL] [Abstract][Full Text] [Related]
9. Changes in phenotype and proliferative potential of human acute myeloblastic leukemia cells in culture with stem cell factor.
Ikeda H; Kanakura Y; Furitsu T; Kitayama H; Sugahara H; Nishiura T; Karasuno T; Tomiyama Y; Yamatodani A; Kanayama Y
Exp Hematol; 1993 Dec; 21(13):1686-94. PubMed ID: 7694869
[TBL] [Abstract][Full Text] [Related]
10. Expression of c-kit receptor (CD117) and CD34 in leukemic cells.
Muroi K; Nakamura M; Amemiya Y; Suda T; Miura Y
Leuk Lymphoma; 1995 Jan; 16(3-4):297-305. PubMed ID: 7536510
[TBL] [Abstract][Full Text] [Related]
11. Primary acute myeloid leukemia cells negative for c-kit receptor protein expression do not proliferate in vitro in response to colony-stimulating factors.
Hirakawa K; Kimura S; Chikayama S; Misawa S; Maekawa T
Leukemia; 1996 Feb; 10(2):279-87. PubMed ID: 8637237
[TBL] [Abstract][Full Text] [Related]
12. c-kit is expressed by primitive human hematopoietic cells that give rise to colony-forming cells in stroma-dependent or cytokine-supplemented culture.
Simmons PJ; Aylett GW; Niutta S; To LB; Juttner CA; Ashman LK
Exp Hematol; 1994 Feb; 22(2):157-65. PubMed ID: 7507857
[TBL] [Abstract][Full Text] [Related]
13. Kit ligand/mast cell growth factor-independent differentiation of mast cells in myelodysplasia and chronic myeloid leukemic blast crisis.
Valent P; Spanblöchl E; Bankl HC; Sperr WR; Marosi C; Pirc-Danoewinata H; Virgolini I; Eichler HG; Agis H; Sillaber C
Blood; 1994 Dec; 84(12):4322-32. PubMed ID: 7527672
[TBL] [Abstract][Full Text] [Related]
14. Early CD34high cells can be separated into KIThigh cells in which transforming growth factor-beta (TGF-beta) downmodulates c-kit and KITlow cells in which anti-TGF-beta upmodulates c-kit.
Sansilvestri P; Cardoso AA; Batard P; Panterne B; Hatzfeld A; Lim B; Lévesque JP; Monier MN; Hatzfeld J
Blood; 1995 Sep; 86(5):1729-35. PubMed ID: 7544639
[TBL] [Abstract][Full Text] [Related]
15. The product of the proto-oncogene c-kit (P145c-kit) is a human bone marrow surface antigen of hemopoietic precursor cells which is expressed on a subset of acute non-lymphoblastic leukemic cells.
Bühring HJ; Ullrich A; Schaudt K; Müller CA; Busch FW
Leukemia; 1991 Oct; 5(10):854-60. PubMed ID: 1720490
[TBL] [Abstract][Full Text] [Related]
16. Characterization of enriched CD34+ cells from healthy volunteers and those from patients treated with chemotherapy plus granulocyte colony-stimulating factor (G-CSF).
Suzuki T; Muroi K; Tomizuka H; Amemiya Y; Miura Y
Stem Cells; 1995 May; 13(3):273-80. PubMed ID: 7542113
[TBL] [Abstract][Full Text] [Related]
17. Asynchronous expression of c-kit and CD34 on leukemic blasts.
Muroi K; Nakamura M; Amemiya Y; Suda T; Miura Y
Br J Haematol; 1993 Nov; 85(3):633-5. PubMed ID: 7510995
[No Abstract] [Full Text] [Related]
18. Differential responses of CD34-positive acute myelogenous leukemic blasts to the costimulating effects of stem cell factor with GM-CSF and/or IL-3.
Min YH; Lee ST; Lee BK; Chong SY; Lee S; Hahn JS; Ko YW
Yonsei Med J; 1995 Mar; 36(1):26-36. PubMed ID: 7537932
[TBL] [Abstract][Full Text] [Related]
19. Human umbilical vein endothelial cells display high-affinity c-kit receptors and produce a soluble form of the c-kit receptor.
Broudy VC; Kovach NL; Bennett LG; Lin N; Jacobsen FW; Kidd PG
Blood; 1994 Apr; 83(8):2145-52. PubMed ID: 7512842
[TBL] [Abstract][Full Text] [Related]
20. Expression of the c-kit proto-oncogene in myeloproliferative disorders and myelodysplastic syndromes.
Siitonen T; Savolainen ER; Koistinen P
Leukemia; 1994 Apr; 8(4):631-7. PubMed ID: 7512174
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
